Covaris And HORIBA Instruments Form Strategic Relationship
WOBURN, Mass., Feb. 13, 2013 /PRNewswire/ -- Covaris, Inc., the leader in focused acoustic technologies for the life sciences, is pleased to announce the establishment of a marketing alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan. This alliance integrates the Covaris Adaptive Focused Acoustics (AFA) and the HORIBA particle sizing technologies into the world's first fully automated formulation preparation station with integrated Process Analytical Technology (PAT).
Under the arrangement, the Covaris FS-220 GMP system will be integrated with HORIBA's LA-950V2 platform, providing point-of-use particle size characterization. This PAT system is ideal for formulation preparation from early animal studies through First-In-Human (FIH) testing. With full 21 CFR Part 11 compliant software, the combined system offers a complete solution in cGLP/cGMP environments.
Carl Beckett, General Manager of Covaris Process Technologies, states that, "We are enthusiastic about this association. This combined system will accelerate drug development by improving the quality of studies up to and including FIH testing. Also, it reduces errors when handing off preparations between the Discovery and Development Research centers and the Contract Research Organizations (CRO) by allowing a completely automated and documented method development. Additionally, as our clients scale to FIH and ultimately clinical processes, they need to ensure the methods in development are phase appropriate and based on scalable technologies."
According to Dr. Mike Pohl, Vice President of HORIBA's Scientific Division, "Our client base ranges from startups to the largest multinational Pharma and Biotech companies. As a result of our entering into this relationship with Covaris, our clients gain access to the most advanced technology. It's critical that the analytic and characterization capabilities keep pace with the formulation technology, through the entire discovery/development cycle." Dr. Pohl notes that many pharmaceutical customers are located along the East Coast. "The combination of our Edison, NJ headquarters plus the Woburn, MA location of Covaris, Inc.; gives HORIBA a strong one-two punch to support these customers. The ability to automate the preparation of formulations, and then document the quality up front prior to a study, will now be readily accessible to our customers."The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand. Covaris Process Technologies designs, develops, and markets systems based on patented Adaptive Focused Acoustic (AFA) technology. The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples. The process is non-contact, isothermal, and rapid. Leading pharmaceutical companies worldwide are using Covaris instruments for Formulation development, of nanosuspensions, liposomes, and nanoemulsions. Information about Covaris Process Technologies is available at http://www.covarisinc.com Information about HORIBA Scientific is available at http://www.horiba.com/scientific SOURCE Covaris, Inc.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV